Leonard Osser will lead Milestone Scientific Inc. again.
Former CEO Osser will now be interim CEO for the Livingston company that develops computerized drug delivery instruments that provide painless and precise injections.
He replaces Leslie Bernhard, who will remain chairman of the board.
“As founder of the company, Leonard Osser has been instrumental in both the growth and strategic vision for the company,” Bernhard said. “While we are continuing our search for a new CEO, this process has been slower than expected, because the company has been focused on several ongoing strategic initiatives that Leonard is spearheading. For this reason, he has graciously agreed to resume the role as CEO pending completion of these major projects and selection of a new long-term CEO.”
She said the board appreciates his support and continued involvement.
“I am more excited than ever about the long-term outlook for Milestone, given the recent FDA approval of our epidural instrument on the heels of our successful clinical trial, the planned launch of our cosmetic instrument and the success of our distribution partnership with Henry Schein for the dental instrument,” Osser said. “We have garnered significant interest in each of these instruments, as well as others, and we look forward to providing further updates in the months ahead.”